The prognostic role of the class III β-tubulin in non-small cell lung cancer (NSCLC) patients receiving the taxane/vinorebine-based chemotherapy: a meta-analysis. [electronic resource]
Producer: 20141203Description: e93997 p. digitalISSN:- 1932-6203
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bridged-Ring Compounds -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Humans
- Lung Neoplasms -- drug therapy
- Odds Ratio
- Prognosis
- Publication Bias
- Taxoids -- administration & dosage
- Treatment Outcome
- Tubulin -- genetics
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.